101 related articles for article (PubMed ID: 6241066)
21. Clinical applications of GnRH agonists in gynaecology.
Preutthipan S
J Med Assoc Thai; 1993 Jan; 76 Suppl 1():11-8. PubMed ID: 8113648
[TBL] [Abstract][Full Text] [Related]
22. The use of gonadotrophin-releasing hormone analogues in gynaecology.
Lo KW; Lau TK
Chin Med J (Engl); 1997 Oct; 110(10):746-9. PubMed ID: 9642302
[No Abstract] [Full Text] [Related]
23. [The use of a gonadotropin-releasing hormone agonist for treating gynecological diseases].
Merser LJ; Jilbert HM; Chen P
Akush Ginekol (Mosk); 1991 Feb; (2):16-20. PubMed ID: 1862845
[No Abstract] [Full Text] [Related]
24. [Clinical uses of goserelin in gynecologic diseases and its safety].
Tan SJ; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):58-60. PubMed ID: 10682460
[No Abstract] [Full Text] [Related]
25. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
Murphy AA; Castellano PZ
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
[TBL] [Abstract][Full Text] [Related]
26. [Structural characteristics of the pathologically changed uterus after treatment with sex hormones].
Akobdzhanian MA; Lipets VIa
Akush Ginekol (Mosk); 1985 Feb; (2):31-4. PubMed ID: 3158227
[No Abstract] [Full Text] [Related]
27. [Clinical use of gossypol in gynecology (author's transl)].
Zhou SW
Zhonghua Fu Chan Ke Za Zhi; 1981 Jul; 16(3):137-41. PubMed ID: 7327034
[No Abstract] [Full Text] [Related]
28. [Selective progesterone receptor modulators: future clinical applications].
Bouchard P; Ouzounian S; Chabbert-Buffet N
Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
[TBL] [Abstract][Full Text] [Related]
29. GnRH-antagonists in reproductive medicine.
Griesinger G; Felberbaum R; Diedrich K
Arch Gynecol Obstet; 2005 Dec; 273(2):71-8. PubMed ID: 15991015
[TBL] [Abstract][Full Text] [Related]
30. [Estrogen-progesterone "add-back" for long-term GNRH analogue therapy].
Levy T; Ben-Rafael Z
Harefuah; 1995 Jun; 128(12):789-92. PubMed ID: 7557691
[No Abstract] [Full Text] [Related]
31. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
Zeng C; Gu M; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
[TBL] [Abstract][Full Text] [Related]
32. [Hormonal treatment of myomata (author's transl)].
Pacin J; Ivan J; Ginelli T; Csonth J
Cesk Gynekol; 1975 Jun; 40(5):345-6. PubMed ID: 1137876
[No Abstract] [Full Text] [Related]
33. [Hormonal replacement treatment: therapeutic protocols].
Jamin C
Contracept Fertil Sex; 1996 Feb; 24(2):147-52. PubMed ID: 8611936
[TBL] [Abstract][Full Text] [Related]
34. Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata.
Takeda T; Osuga K; Miyake A; Wakabayashi A; Morishige K; Kimura T
Gynecol Endocrinol; 2008 Dec; 24(12):724-6. PubMed ID: 19172544
[TBL] [Abstract][Full Text] [Related]
35. [Effect of androgens on energetic processes in muscle tissue in uterine fibromoma].
Shevniuk LA
Pediatr Akus Ginekol; 1971; 2():58-60. PubMed ID: 5560608
[No Abstract] [Full Text] [Related]
36. [Conservative therapy of genital endometriosis].
Pimenova LI; Teteliutina FK; Serebrennikova GK; Starostin SV; Churshin AD
Sov Med; 1989; (7):119-22. PubMed ID: 2799514
[No Abstract] [Full Text] [Related]
37. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
39. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
Hilário SG; Bozzini N; Borsari R; Baracat EC
Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
[TBL] [Abstract][Full Text] [Related]
40. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
